All stock lists
Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
Healthcare · Biotechnology
0.72-0.02 (-2.69%)
Insider Score
––Not scored
OCGN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
OCGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 1.49 M | 1.53 M | -193.00 K | 1.75 M | 1.37 M |
| Revenue Growth (YoY) | 8.38 % | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | 7.24 M | 8.12 M | 6.13 M | 8.23 M | 6.77 M |
| R&D Expense | 10.69 M | 11.26 M | 10.67 M | 11.15 M | 8.40 M |
| Operating Expenses | 17.93 M | 19.37 M | 16.80 M | 19.38 M | 15.17 M |
| Operating Income | -16.44 M | -17.84 M | -17.00 M | -17.63 M | -13.79 M |
| Pretax Income | -24.88 M | -19.18 M | -17.71 M | -20.05 M | -14.74 M |
| Tax Provision | — | — | — | — | — |
| Net Income | -24.88 M | -19.18 M | -17.71 M | -20.05 M | -14.74 M |
| EPS (Basic) | -0.07 | -0.06 | -0.06 | -0.06 | -0.05 |
| EPS (Diluted) | -0.07 | -0.06 | -0.06 | -0.06 | -0.05 |
| Shares Outstanding | 338.68 M | 320.42 M | 312.34 M | 312.32 M | 292.07 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.